Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00138502 · ClinicalTrials.gov registry record
Funguria in Hospitalized Patients
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 926
- Enrollment target
NCT00138502 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 926 participants.
The verdict
NCT00138502 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 926 participants
- Enrollment target
Study Summary
The purpose of the study is to test the hypothesis that a subpopulation of patients with candiduria are at significant risk for disseminated disease and would benefit from treatment, while others are at low risk from complications and therefore require no antifungal therapy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 926 participants |
| Start Date | 2001-09-17 |
| Est. Completion | 2008-12-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00138502
The ClinicalTrials.gov registry entry for NCT00138502 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 926 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00138502 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00138502 about?
NCT00138502 is a clinical study titled "Funguria in Hospitalized Patients". The purpose of the study is to test the hypothesis that a subpopulation of patients with candiduria are at significant risk for disseminated disease and would benefit from treatment, while others are at low risk from complications and therefore require no antifungal therapy.
What is the current status of trial NCT00138502?
This trial is currently completed. The enrollment target is 926 participants. The study started on 2001-09-17. Estimated completion is 2008-12-08.
Who is sponsoring clinical trial NCT00138502?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.